Sven Schippling

11.9k citations

117 papers · 5.8k indexed · 3 hit papers · h-index 39

Impact in

Pathology and Forensic Medicine top 0.2%
- Multiple Sclerosis Research Studies
Ophthalmology top 0.2%
- Retinal and Optic Conditions
- Glaucoma and retinal disorders
- Ocular Diseases and Behçet’s Syndrome

Papers in

Pathology and Forensic Medicine 76
- Multiple Sclerosis Research Studies 74
Ophthalmology 20
- Retinal and Optic Conditions 12
- Glaucoma and retinal disorders 6

Co-authors: Roland Martinꝉ Axel Petzold Ari Green Friedemann Paul Mireia Sospedra Fiona Costello John C. Rothwell Peter A. Calabresi
Journals: Neurology (20 papers)Journal of Neurology (7 papers)Multiple Sclerosis Journal (7 papers)NeuroImage Clinical (4 papers)Neuroradiology (4 papers)
Partner nations: Germany Switzerland United States

In The Last Decade

Sven Schippling

106 papers receiving 5.7k citations

Hit Papers

align trajectories log scale

Update on the diagnosis and treatment of neuromyelitis optica: Recommendations of the Neuromyelitis Optica Study Group (NEMOS) 2013 · 417 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2013 Journal of Neurology
2012 PLoS ONE
2010 The Lancet Neurology

Peers

Countries citing papers authored by Sven Schippling

Since Specialization

Citations

This map shows the geographic impact of Sven Schippling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sven Schippling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sven Schippling more than expected).

Fields of papers citing papers by Sven Schippling

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sven Schippling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sven Schippling. The network helps show where Sven Schippling may publish in the future.

Co-authors

The 25 scholars most cited alongside Sven Schippling, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Sven Schippling Line = papers co-authored together Sven Schippling links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	BrainLossNet: a fast, accurate and robust method to estimate brain volume loss from longitudinal MRI International Journal of Computer Assisted Radiology and Surgery ·Roland Opfer, Julia Krüger, Thomas Buddenkotte, Lothar Spies, Finn Behrendt, Sven Schippling, Ralph Buchert	2024	1
2	4D Deep Learning for Multiple Sclerosis Lesion Activity Segmentation Nils Gessert, Marcel Bengs, Julia Krüger, Roland Opfer, Ann‐Christin Ostwaldt, Praveena Manogaran, Sven Schippling, Alexander Schlaefer	2020	1
3	60/30: 60% of the Morbidity-Associated Multiple Sclerosis Disease Burden Comes From the 30% of Persons With Higher Impairments Frontiers in Neurology ·Marco Kaufmann, Milo A. Puhan, Anke Salmen, Christian P. Kamm, Zina‐Mary Manjaly, Pasquale Calabrese, Sven Schippling, Stefanie Müller, Jens Kühle, Caroline Pot, Claudio Gobbi, Nina Steinemann, Viktor von Wyl, (unknown)	2020	11
4	Efficacy and Safety of Alemtuzumab Through 9 Years of Follow-up in Patients with Highly Active Disease: Post Hoc Analysis of CARE-MS I and II Patients in the TOPAZ Extension Study CNS Drugs ·Tjalf Ziemssen, Ann Bass, Regina Berkovich, Giancarlo Comi, Sara Eichau, Jeremy Hobart, Samuel F. Hunter, Christopher LaGanke, Volker Limmroth, Daniel Pelletier, Carlo Pozzilli, Sven Schippling, Lívia Sousa, Anthony Traboulsee, Bernard M.J. Uitdehaag, Bart Van Wijmeersch, Zia Choudhry, Nadia Daizadeh, B. Singer, (unknown)	2020	43
5	Effect of Ozanimod on Symbol Digit Modalities Test Performance in Relapsing MS Multiple Sclerosis and Related Disorders ·John DeLuca, Sven Schippling, Xavier Montalbán, Ludwig Kappos, Bruce Cree, Cristoforo Comi, Douglas L. Arnold, Hans‐Peter Hartung, James K. Sheffield, Hongjuan Liu, Diego Augusto Santos Silva, Jeffrey A. Cohen	2020	27
6	Anatomically constrained tractography facilitates biologically plausible fiber reconstruction of the optic radiation in multiple sclerosis NeuroImage Clinical ·M. Horbruegger, Kristian Loewe, Joern Kaufmann, Markus Wagner, Sven Schippling, Marc Pawlitzki, Mircea Ariel Schoenfeld	2019	18
7	Within-patient fluctuation of brain volume estimates from short-term repeated MRI measurements using SIENA/FSL Journal of Neurology ·Roland Opfer, Ann‐Christin Ostwaldt, Christine Walker-Egger, Praveena Manogaran, Maria Pia Sormani, Nicola De Stefano, Sven Schippling	2018	18
8	Exploring experimental autoimmune optic neuritis using multimodal imaging NeuroImage ·Praveena Manogaran, Christine Walker-Egger, Marijana Samardzija, Conny Waschkies, Christian Grimm, Markus Rudin, Sven Schippling	2018	18
9	Alemtuzumab Durably Slows Brain Volume Loss Over 6 Years in the Absence of Continuous Treatment in Patients With Active RRMS Who Were Treatment-Naive (CARE-MS I) or Had an Inadequate Response to Prior Therapy (CARE-MS II) (P2.104) Neurology ·Anthony Traboulsee, Michael Barnett, Gıancarlo Comı, Christopher LaGanke, Daniel Pelletier, Àlex Rovira, Sven Schippling, David Margolin, Karthinathan Thangavelu, Kunio Nakamura, Douglas L. Arnold	2017	1
10	Estimates of age-dependent cutoffs for pathological brain volume loss using SIENA/FSL—a longitudinal brain volumetry study in healthy adults Neurobiology of Aging ·Roland Opfer, Ann‐Christin Ostwaldt, Maria Pia Sormani, Carola Gocke, Christine Walker-Egger, Praveena Manogaran, Nicola De Stefano, Sven Schippling	2017	23
11	Alemtuzumab-Treated Patients with RRMS Demonstrate Durable Slowing of Brain Volume Loss Over 5 Years Despite Most Being Treatment-Free for 4 Years: CARE-MS I and II Extension Study (S51.001) Neurology ·Sven Schippling, Jeffrey A. Cohen, Alasdair Coles, D. A. S. Compston, Edward Fox, Massimo Filippi, Hans‐Peter Hartung, Eva Havrdová, Krzysztof Selmaj, Frederik Barkhof, David Margolin, Karthinathan Thangavelu, Douglas L. Arnold	2016	2
12	MRI FLAIR lesion segmentation in multiple sclerosis: Does automated segmentation hold up with manual annotation? NeuroImage Clinical ·Christine Egger, Roland Opfer, Chenyu Wang, Timo Kepp, Maria Pia Sormani, Lothar Spies, Michael Barnett, Sven Schippling	2016	84
13	RNFL as a Surrogate Outcome Marker in Patients with Multiple Sclerosis: Design of the OCTiMS study, Baseline Characteristics and OCT Test Reproducibility (P7.224) Neurology ·Peter A. Calabresi, Frederik Barkhof, Ari Green, Randy H. Kardon, Friedemann Paul, Jaume Sastre‐Garriga, Sven Schippling, Patrick Vermersch, Pablo Villoslada, Catherine Agoropoulou, Ying Zhang, Diego Silva, Axel Petzold	2015	1
14	The OSCAR-IB Consensus Criteria for Retinal OCT Quality Assessment PLoS ONE ·Prejaas Tewarie, Lisanne J. Balk, Fiona Costello, Ari Green, Roland Martinꝉ, Sven Schippling, Axel Petzold Hit paper breakdown →	2012	430
15	Retinal Damage in Multiple Sclerosis Disease Subtypes Measured by High-Resolution Optical Coherence Tomography SHILAP Revista de lepidopterología ·Timm Oberwahrenbrock, Sven Schippling, Marius Ringelstein, Falko Kaufhold, Hanna Zimmermann, Nazmiye Keser, Kim Lea Young, Jens Harmel, Hans‐Peter Hartung, Roland Martinꝉ, Friedemann Paul, Orhan Aktaş, Alexander U. Brandt	2012	126
16	Future MS care: a consensus statement of the MS in the 21st Century Steering Group Journal of Neurology ·Peter Rieckmann, Alexey Boyко, Diego Centonze, Alasdair Coles, Irina Elovaara, Eva Havrdová, O. R. Hommes, Jacques LeLorier, Sarah A. Morrow, Celia Oreja‐Guevara, Nick Rijke, Sven Schippling	2012	25
17	Diagnostik und Therapie der Neuromyelitis optica: Konsensusempfehlungen der Neuromyelitis optica Studiengruppe Der Nervenarzt ·Corinna Trebst, Achim Berthele, Sven Jarius, Tania Kümpfel, Sven Schippling, Brigitte Wildemann, Christian Wilke	2011	0
18	Neutrophils in multiple sclerosis are characterized by a primed phenotype Journal of Neuroimmunology ·Matthias Naegele, Kati Tillack, Stefanie Reinhardt, Sven Schippling, Roland Martinꝉ, Mireia Sospedra	2011	166
19	Increased lipoprotein oxidation in alzheimer’s disease Free Radical Biology and Medicine ·Sven Schippling, Anatol Kontush, Sönke Arlt, Carsten Buhmann, Hans-Jörg Stürenburg, Ulrike Mann, Tomas Müller‐Thomsen, Ulrike Beisiegel	2000	171
20	Plasma ubiquinol‐10 as a marker for disease: Is the assay worthwhile? BioFactors ·Anatol Kontush, Sven Schippling, T. Spranger, Ulrike Beisiegel	1999	23

About Sven Schippling

Sven Schippling is a scholar working on Pathology and Forensic Medicine, Ophthalmology, Rheumatology, Neurology and Neurology, having authored 117 papers that have together received 5.8k indexed citations. Recurring topics across this work include Multiple Sclerosis Research Studies (74 papers), Systemic Lupus Erythematosus Research (19 papers), Polyomavirus and related diseases (15 papers), Peripheral Neuropathies and Disorders (13 papers), Retinal and Optic Conditions (12 papers), Transcranial Magnetic Stimulation Studies (7 papers), Optical Coherence Tomography Applications (7 papers) and Glaucoma and retinal disorders (6 papers). The work is most often cited by research in Pathology and Forensic Medicine (3.0k citations), Ophthalmology (1.4k citations), Neurology (777 citations), Neurology (1.4k citations) and Rheumatology (1.0k citations). Sven Schippling has collaborated with scholars based in Germany, Switzerland and United States. Frequent co-authors include Roland Martinꝉ, Axel Petzold, Ari Green, Friedemann Paul, Mireia Sospedra, Fiona Costello, John C. Rothwell, Peter A. Calabresi, Lisanne J. Balk and Prejaas Tewarie. Their work appears in journals such as Neurology, Journal of Neurology, Multiple Sclerosis Journal, NeuroImage Clinical and Neuroradiology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact